The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Leptospirosis in “Eco-Challenge” Athletes, Malaysian Borneo, 2000
Open accessAbstract
Adventure travel is becoming more popular, increasing the likelihood of contact with unusual pathogens.We investigated an outbreak of leptospirosis in "Eco-Challenge" multisport race athletes to determine illness etiology and implement public health measures.Of 304 athletes, we contacted 189 (62%) from the United States and 26 other countries.Eighty (42%) athletes met our case definition.Twentynine (36%) case-patients were hospitalized; none died.Logistic regression showed swimming in the Segama River (relative risk [RR]=2.0;95% confidence interval [CI]=1.3 to 3.1) to be an independent risk factor.Twenty-six (68%) of 38 case-patients tested positive for leptospiral antibodies.Taking doxycycline before or during the race was protective (RR=0.4,95% CI=0.2 to 1.2) for the 20 athletes who reported using it.Increased adventure travel may lead to more frequent exposure to leptospires, and preexposure chemoprophylaxis for leptospirosis (200 mg oral doxycycline/ week) may decrease illness risk.Efforts are needed to inform adventure travel participants of unique infections such as leptospirosis. E ach year, 60 million Americans travel abroad.Increasingly, these persons are traveling to more remote and exotic destinations.Adventure travel is now the largest growing segment of the leisure travel industry, with a growth rate of 10% per year since 1985 (Adventure Travel Society, pers.comm.).This travel has led to an increasing risk for contact with pathogens uncommon in industrialized countries, especially for participants in adventure sports and extreme travel.Both of these pursuits may predispose persons to infection with unusual organisms through exposures to lakes, rivers, caves, and canyons, as well as insect vectors.These illnesses may be unfamiliar to practitioners in the travelers' home countries, and symptoms may go unrecognized.Leptospirosis, a bacterial zoonotic infection, is more frequently found in developing countries, and its protean early symptoms may be difficult to diagnose clinically.Prevention of leptospirosis in humans has previously relied on mechanical barriers and avoidance (1), but limited published data suggest that preexposure chemoprophylaxis may be beneficial to some groups (2-4).From September 7 to September 11, 2000, the Idaho Department of Health, the Los Angeles County Department of Health Services, and the GeoSentinel Network (an international surveillance network of travel clinics) notified the Centers for Disease Control and Prevention (CDC) of at least 20 cases of febrile illness.The illness was characterized by the acute onset of high fever, chills, headache, and myalgias; major laboratory test abnormalities and important pulmonary or central nervous system involvement were absent.All ill persons had participated in the Eco-Challenge-Sabah 2000 multisport endurance race, held in Malaysian Borneo August 21-September 1, 2000.Three hundred four athletes from 26 countries and 29 U.S. states competed in the 10-day endurance event.Segments of the event included jungle trekking, prolonged swimming and kayaking (both in fresh and ocean water), spelunking (caving), climbing, and mountain biking.Symptoms and exposure history, as well as initial laboratory testing, suggested that the illness was leptospirosis.We undertook an investigation to determine the etiology of the illness in the athletes and to make public health recommendations.We report on the results of this investigation and discuss recommendations for preventing leptospirosis in adventure travelers. Methods Epidemiologic InvestigationUpon identification of the first ill athletes, a complete list of U.S. and international participants in the Eco-702
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Principles and Practice of Infectious Diseases.
(1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-9-818_5 · Cited by 12,025
Levett, P. N. (2001) · Clinical Microbiology Reviews · doi:10.1128/cmr.14.2.296-326.2001 · Cited by 2,371
Adler, B., & de la Peña Moctezuma, A. (2010) · Veterinary Microbiology · doi:10.1016/j.vetmic.2009.03.012 · Cited by 2,311
Innis, B. L., Nisalak, A., Nimmannitya, S., Kusalerdchariya, S., Chongswasdi, V., Suntayakorn, S., Puttisri, P., & Hoke, C. H. (1989) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.1989.40.418 · Cited by 711
Epidemic Leptospirosis Associated with Pulmonary Hemorrhage—Nicaragua, 1995
Trevejo, R. T., Rigau‐Pérez, J. G., Ashford, D. A., McClure, E. M., Jarquín‐González, C., Amador, J. J., de los Reyes, J. O., Gonzalez, A., Zaki, S. R., Shieh, W., et al. (1998) · The Journal of Infectious Diseases · doi:10.1086/314424 · Cited by 440
Self-citationAn Efficacy Trial of Doxycycline Chemoprophylaxis against Leptospirosis
Takafuji, E. T., Kirkpatrick, J. W., Miller, R. N., Karwacki, J. J., Kelley, P. W., Gray, M. R., McNeill, K. M., Timboe, H. L., Kane, R. E., & Sanchez, J. L. (1984) · New England Journal of Medicine · doi:10.1056/nejm198402233100805 · Cited by 314
Morgan, J., Bornstein, S. L., Karpati, A. M., Bruce, M., Bolin, C. A., Austin, C. C., Woods, C. W., Lingappa, J., Langkop, C., Davis, B., et al. (2002) · Clinical Infectious Diseases · doi:10.1086/340615 · Cited by 297
Self-citationLeptospirosis, Water Sports, and Chemoprophylaxis
Haake, D. A., Dundoo, M., Cader, R., Kubak, B. M., Hartskeerl, R. A., Sejvar, J. J., & Ashford, D. A. (2002) · Clinical Infectious Diseases · doi:10.1086/339942 · Cited by 160
Self-citationRandomized controlled trial of doxycycline prophylaxis against leptospirosis in an endemic area
SEHGAL, S. C., Sugunan, A. P., Murhekar, M. V., Sharma, S., & Vijayachari, P. (2000) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(99)00134-x · Cited by 145
Two Methods for Rapid Serological Diagnosis of Acute Leptospirosis
Levett, P. N., Branch, S. L., Whittington, C. U., Edwards, C. N., & Paxton, H. (2001) · Clinical and Diagnostic Laboratory Immunology · doi:10.1128/cdli.8.2.349-351.2001 · Cited by 115
An outbreak and review of cave-associated histoplasmosis capsulati
Sacks, J. J., Ajello, L., & Crockett, L. K. (1986) · Medical Mycology · doi:10.1080/02681218680000471 · Cited by 45
Cited by
Leptospirosis: a zoonotic disease of global importance
Bharti, A. R., Nally, J. E., Ricaldi, J. N., Matthias, M. A., Diaz, M. M., Lovett, M. A., Levett, P. N., Gilman, R. H., Willig, M. R., Gotuzzo, E., et al. (2003) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(03)00830-2 · Cited by 2,458
Global Morbidity and Mortality of Leptospirosis: A Systematic Review
Costa, F., Hagan, J. E., Calcagno, J., Kane, M., Torgerson, P., Martinez-Silveira, M. S., Stein, C., Abela-Ridder, B., & Ko, A. I. (2015) · PLOS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0003898 · Cited by 1,967
Tomblyn, M., Chiller, T., Einsele, H., Gress, R., Sepkowitz, K., Storek, J., Wingard, J. R., Young, J.-A. H., & Boeckh, M. A. (2009) · Biology of Blood and Marrow Transplantation · doi:10.1016/j.bbmt.2009.06.019 · Cited by 1,797
Haake, D. A., & Levett, P. N. (2015) · Current Topics in Microbiology and Immunology · doi:10.1007/978-3-662-45059-8_5 · Cited by 979
Actionable Diagnosis of Neuroleptospirosis by Next-Generation Sequencing
Wilson, M. R., Naccache, S. N., Samayoa, E., Biagtan, M., Bashir, H., Yu, G., Salamat, S. M., Somasekar, S., Federman, S., Miller, S., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1401268 · Cited by 977
Metadata
- Authors
- Sejvar, J., Bancroft, E., Winthrop, K., Bettinger, J., Bajani, M., Bragg, S., Shutt, K., Kaiser, R., Marano, N., Popovic, T., Tappero, J., Ashford, D., Mascola, L., Vugia, D., Perkins, B., Rosenstein, N., & the Eco-Challenge Investigation Team
- Venue
- Emerging Infectious Diseases
- Published
- 2003-06
- Volume
- 9
- Issue
- 6
- Pages
- 702-707
- ISSN
- 1080-6040 (ISSN-L)
- 1080-6059
- OpenAlex
- W2055041371
- Cited by
- 294
- References
- 11
- FWCI
- 8.70
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.